DBV Technologies S.A. (DBVTF)
DBVTF is quoted over the counter, not listed on an exchange. DBV Technologies S.A. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | DBVTF, quoted over the counter |
| SEC CIK | 0001613780 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Business address | Chatillon |
| Incorporated in | France |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Accordingly, substantial doubt exists about the Company's ability to continue as a going concern within twelve months after the date these condensed consolidated financial statements are issued." | 10-Q 2026-10-28 |
| Cash and burn | $165.7M cash; operating cash flow -$47.1M a quarter. | Report 2026-09-30 |
| Shares outstanding | 62,877,761 (2026-10-26); 33,822,724 a year earlier; 19,257,711 three years earlier. 3y figure adjusted for split (1-for-2 overall). | Cover page 2026-10-26 |
| Reverse splits, 3 years | 1; latest 1-for-2 on 2024-06-07 | Source 2024-06-07 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-07-27 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Deloitte & Associés, Paris-La Défense, France | PCAOB Form AP 2026-04-29 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $15.5M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $1.6M | -$64.5M | -$51.5M | $165.7M | $200K | $3.8M | 10-Q 2026-10-28 |
| Q2 2026 2026-06-30 | $700K | -$50.4M | -$52.6M | $174.9M | No debt tags | $5.0M | 10-Q 2026-07-16 |
| Q1 2026 2026-03-31 | $900K | -$47.6M | -$49.1M | $229.2M | No debt tags | $5.8M | 10-Q 2026-04-30 |
| Q4 2025 2025-12-31 | $636K | -$44.8M | -$35.2M | $194.2M | $0 | $5.7M | 10-K 2026-03-26 |
| Q3 2025 2025-09-30 | $2.8M | -$33.2M | -$32.4M | $69.8M | No debt tags | $5.6M | 10-Q 2026-10-28 |
| Q2 2025 2025-06-30 | $1.5M | -$41.9M | -$33.9M | $103.2M | No debt tags | $3.9M | 10-Q 2026-07-16 |
| Q1 2025 2025-03-31 | $800K | -$27.1M | -$19.7M | $13.0M | No debt tags | $3.5M | 10-Q 2026-04-30 |
| Q4 2024 2024-12-31 | $511K | -$23.0M | -$12.3M | $32.5M | No debt tags | $4.2M | 10-K 2026-03-26 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-07-27 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-10-28 |
| Latest current report | 8-K | 2026-10-28 |
| Latest proxy | DEF 14A | 2026-05-11 |
Source: SEC EDGAR submissions feed, 578 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier